Cargando…
Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease
The growth factor glucagon-like peptide-1 (GLP-1) is neuroprotective in several animal models of neurodegeneration. Here, we analyzed the neuroprotective effects of a novel protease-resistant GLP-1 analogue, (Val(8))GLP-1-Glu-PAL, which has advantages over older analogues, such as improvement of hip...
Autores principales: | Li, Lin, Liu, Ke, Zhao, Juan, Holscher, Christian, Li, Guang-lai, Liu, Yue-ze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810999/ https://www.ncbi.nlm.nih.gov/pubmed/27073388 http://dx.doi.org/10.4103/1673-5374.177742 |
Ejemplares similares
-
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014) -
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
por: Reich, Niklas, et al.
Publicado: (2022) -
Neuroprotective effect of Val variant of BDNF Val66Met polymorphism on hippocampus is modulated by the severity of menstrual pain
por: Li, Wei-Chi, et al.
Publicado: (2021) -
Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
por: Wu, Heng, et al.
Publicado: (2022) -
E-Pal
por: Speelman-Verburgh, Marijke, et al.
Publicado: (2020)